Immatics at the Allogeneic Cell Therapies Summit 2019 (May 7-9) in Boston, MA (USA)
Meet Immatics at the Allogeneic Cell Therapies Summit 2019 (May 7-9) in Boston, MA and learn about the success factors of Immatics’ immunotherapies:
May 8th, 3pm - 3.30pm
Talk: "Novel Allogeneic Cell Therapies for Treatment of Solid Cancers"
Speaker: Harpreet Singh (CEO Immatics US)
May 9th, 10.30am - 11am
Talk: "ACTallo®: Off-the-Shelf γδ T Cell Therapy Engineered Against Novel Tumor Targets"
Speaker: Yannick Bulliard (Director Translational Development)
We’re looking forward to interesting and exciting discussions.
Further information on Allogeneic Cell Therapies Summit 2019 here.